A previous report by Kato et al. demonstrated that metformin treatment inhibited gastric cancer cell proliferation in vitro and in vivo by blocking the cell cycle with decreased expression of Cyclin D1 [36]. The gene discussed is CCND1; the disease is gastric cancer.